Analysis for Laboratorios Farmaceuticos Rovi
Description & usage
Laboratorios Rovi is a Spanish pharmaceutical company combining proprietary products with contract manufacturing services for biopharma partners. It benefits from a blended model of branded medicines and value-added production. Key valuation drivers are product sales, CDMO utilization, pipeline progress, and regulatory approvals.
Basic info
- Symbol
- ROVI.MC
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 11.1 years
- Last trading day
- 04/02/2026
Basic info
- Symbol
- ROVI.MC
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 11.1 years
- Last trading day
- 04/02/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Analysis summary
Technical asset picture
Laboratorios Farmaceuticos Rovi (ROVI.MC) currently has a total score of 80 points, placing it in the very strong range. The score is made up of Performance (80), Stability (72) and Trend (93). All three sub-scores are currently above average.
Performance scores 80 points (very strong). Key strength: 1Y return at 75.9 %. Even the weakest return is still strong in absolute terms: 5Y return at 68.0 %. This points to a sharper upswing more recently.
Stability scores 72 points (strong). Key strength: Sharpe ratio (90d) at 3.16. Main drag: max drawdown (1Y) at -49.6 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 93 points (very strong). Key strength: trend strength at 0.95. Even the weakest metric remains solid in absolute terms: SMA50 distance at 5.7 %.
Overall, the very strong total score is driven mainly by Trend and Performance; Stability is the biggest lever for improvement. On a metric level, Sharpe ratio (90d) stands out, while max drawdown (1Y) is the main weak spot.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: Euro area PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.